{"transactions":[{"id":691671,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-08-10T20:30:09.000Z","date":"2026-08-07","kind":"sale","planned":true,"acquired":false,"shares":17000,"price":10.0821,"value":171395.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.18. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This amount includes 138,049 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":157316,"source":{"system":"sec-edgar","filing":"0001193125-26-342485","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312526342485/ownership.xml","form_type":"4"}},{"id":895817,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-02-18T21:30:13.000Z","date":"2026-02-13","kind":"sale","planned":true,"acquired":false,"shares":13871,"price":7.7826,"value":107952.4446,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025 and the sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units (\"RSUs\"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.58 to $7.96. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This amount includes 138,049 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":174316,"source":{"system":"sec-edgar","filing":"0001193125-26-057159","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312526057159/ownership.xml","form_type":"4"}},{"id":936746,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock options (right to buy)","published_at":"2026-01-16T21:30:05.000Z","date":"2026-01-14","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The annual option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. 25% of the option vests on January 14, 2027, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on February 14, 2027."}],"balance_after":150000,"derivative":{"exercise_price":8.26,"expiration_date":"2036-01-14","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001193125-26-015426","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312526015426/ownership.xml","form_type":"4"}},{"id":936745,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2026-01-16T21:30:05.000Z","date":"2026-01-14","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 14, 2026, the Reporting Person was granted 50,000 restricted stock units (\"RSUs\"), which will be settled in shares of common stock, par value $0.0001. 25% of the RSUs shall vest on each of the first, second, third and fourth anniversary beginning on January 14, 2027. Notwithstanding the foregoing, upon termination of the Reporting Person's Service by the Company without cause, provided that such termination occurs after the first Vesting Date, then a prorata portion of the RSUs shall accelerate in an amount equal to the product of (x) the number of RSUs scheduled to vest on the next Vesting Date and (y) a fraction, the numerator of which is the number of completed months of service the Awardee worked since the most recent Vesting Date through the date of Awardees termination of Service and the denominator of which is 12. The RSUs, to the extent not accelerated in accordance with this paragraph shall be forfeited upon such Reporting Person's termination of service."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes 173,561 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":188187,"source":{"system":"sec-edgar","filing":"0001193125-26-015426","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312526015426/ownership.xml","form_type":"4"}},{"id":1013099,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock options (right to buy)","published_at":"2025-10-27T20:23:19.000Z","date":"2025-10-27","kind":"exercise","planned":true,"acquired":false,"shares":8973,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vested on February 13, 2024, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 13, 2024."}],"balance_after":22106,"derivative":{"exercise_price":4.26,"exercise_date":"2024-02-13","expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":8973},"source":{"system":"sec-edgar","filing":"0001193125-25-251639","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312525251639/ownership.xml","form_type":"4"}},{"id":1013098,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock options (right to buy)","published_at":"2025-10-27T20:23:19.000Z","date":"2025-10-24","kind":"exercise","planned":true,"acquired":false,"shares":18660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vested on February 13, 2024, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 13, 2024."}],"balance_after":31079,"derivative":{"exercise_price":4.26,"exercise_date":"2024-02-13","expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":18660},"source":{"system":"sec-edgar","filing":"0001193125-25-251639","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312525251639/ownership.xml","form_type":"4"}},{"id":1013097,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-10-27T20:23:19.000Z","date":"2025-10-27","kind":"sale","planned":true,"acquired":false,"shares":8973,"price":17.14,"value":153797.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.00 to $17.31. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes 123,561 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":138187,"source":{"system":"sec-edgar","filing":"0001193125-25-251639","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312525251639/ownership.xml","form_type":"4"}},{"id":1013096,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-10-27T20:23:19.000Z","date":"2025-10-27","kind":"exercise","planned":true,"acquired":true,"shares":8973,"price":4.26,"value":38224.98,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes 123,561 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":147160,"source":{"system":"sec-edgar","filing":"0001193125-25-251639","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312525251639/ownership.xml","form_type":"4"}},{"id":1013095,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-10-27T20:23:19.000Z","date":"2025-10-24","kind":"sale","planned":true,"acquired":false,"shares":18660,"price":17.01,"value":317406.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.79 to $17.38. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes 123,561 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":138187,"source":{"system":"sec-edgar","filing":"0001193125-25-251639","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312525251639/ownership.xml","form_type":"4"}},{"id":1013094,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-10-27T20:23:19.000Z","date":"2025-10-24","kind":"exercise","planned":true,"acquired":true,"shares":18660,"price":4.26,"value":79491.6,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes 123,561 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":156847,"source":{"system":"sec-edgar","filing":"0001193125-25-251639","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000119312525251639/ownership.xml","form_type":"4"}},{"id":1263272,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-02-18T22:40:26.000Z","date":"2025-02-14","kind":"sale","planned":true,"acquired":false,"shares":7134,"price":8.7559,"value":62464.5906,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024 and the sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units (\"RSUs\"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.30 to $9.14. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This amount includes 123,561 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":138187,"source":{"system":"sec-edgar","filing":"0000950170-25-022512","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017025022512/ownership.xml","form_type":"4"}},{"id":1283719,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock options (right to buy)","published_at":"2025-02-04T22:11:39.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":228800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The annual option award was made in accordance with the terms of the issuer's 2024 Equity Compensation Plan. 25% of the option vests on January 31, 2026, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on February 28, 2026."}],"balance_after":228800,"derivative":{"exercise_price":9.79,"expiration_date":"2035-01-31","underlying":"Common Stock","underlying_shares":228800},"source":{"system":"sec-edgar","filing":"0000950170-25-013697","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017025013697/ownership.xml","form_type":"4"}},{"id":1283718,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2025-02-04T22:11:39.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":68100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 31, 2025, the Reporting Person was granted 68,100 restricted stock units (\"RSUs\"), which will be settled in shares of common stock, par value $0.0001. 25% of the RSUs shall vest on each of the first, second, third and fourth anniversary beginning on January 31, 2026. Notwithstanding the foregoing, upon termination of the Reporting Person's Service by the Company without cause, provided that such termination occurs after the first Vesting Date, then a pro rata portion of the RSUs shall accelerate in an amount equal to the product of (x) the number of RSUs scheduled to vest on the next Vesting Date and (y) a fraction, the numerator of which is the number of completed months of service the Awardee worked since the most recent Vesting Date through the date of Awardees termination of Service and the denominator of which is 12. The RSUs, to the extent not accelerated in accordance with this paragraph shall be forfeited upon such Reporting Person's termination of service."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amount includes 142,047 unvested RSUs subject to each grant's vesting schedule as previously reported."}],"balance_after":145321,"source":{"system":"sec-edgar","filing":"0000950170-25-013697","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017025013697/ownership.xml","form_type":"4"}},{"id":1474671,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Options to purchase common stock","published_at":"2024-06-18T21:58:48.000Z","date":"2024-06-18","kind":"exercise","planned":true,"acquired":false,"shares":2322,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vested on February 13, 2024, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 13, 2024."}],"balance_after":49739,"derivative":{"exercise_price":4.26,"exercise_date":"2024-02-13","expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":2322},"source":{"system":"sec-edgar","filing":"0000950170-24-075071","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024075071/ownership.xml","form_type":"4"}},{"id":1474670,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Options to purchase common stock","published_at":"2024-06-18T21:58:48.000Z","date":"2024-06-18","kind":"exercise","planned":true,"acquired":false,"shares":1770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vested on February 1, 2023, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 2, 2023."}],"balance_after":31057,"derivative":{"exercise_price":14.1,"exercise_date":"2023-02-01","expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":1770},"source":{"system":"sec-edgar","filing":"0000950170-24-075071","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024075071/ownership.xml","form_type":"4"}},{"id":1474669,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Options to purchase common stock","published_at":"2024-06-18T21:58:48.000Z","date":"2024-06-18","kind":"exercise","planned":true,"acquired":false,"shares":11667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F8","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan and is fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan and is fully vested."}],"balance_after":0,"derivative":{"exercise_price":30,"expiration_date":"2024-10-22","underlying":"Common Stock","underlying_shares":11667},"source":{"system":"sec-edgar","filing":"0000950170-24-075071","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024075071/ownership.xml","form_type":"4"}},{"id":1474668,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Options to purchase common stock","published_at":"2024-06-18T21:58:48.000Z","date":"2024-06-17","kind":"exercise","planned":true,"acquired":false,"shares":1770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vested on February 13, 2024, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 13, 2024."}],"balance_after":52061,"derivative":{"exercise_price":4.26,"exercise_date":"2024-02-13","expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":1770},"source":{"system":"sec-edgar","filing":"0000950170-24-075071","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024075071/ownership.xml","form_type":"4"}},{"id":1474667,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Options to purchase common stock","published_at":"2024-06-18T21:58:48.000Z","date":"2024-06-17","kind":"exercise","planned":true,"acquired":false,"shares":9333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F8","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan and is fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan and is fully vested."}],"balance_after":11667,"derivative":{"exercise_price":30,"expiration_date":"2024-10-22","underlying":"Common Stock","underlying_shares":9333},"source":{"system":"sec-edgar","filing":"0000950170-24-075071","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024075071/ownership.xml","form_type":"4"}},{"id":1474666,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Options to purchase common stock","published_at":"2024-06-18T21:58:48.000Z","date":"2024-06-14","kind":"exercise","planned":true,"acquired":false,"shares":12487,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vested on February 13, 2024, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 13, 2024."}],"balance_after":53831,"derivative":{"exercise_price":4.26,"exercise_date":"2024-02-13","expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":12487},"source":{"system":"sec-edgar","filing":"0000950170-24-075071","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024075071/ownership.xml","form_type":"4"}},{"id":1474665,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Options to purchase common stock","published_at":"2024-06-18T21:58:48.000Z","date":"2024-06-14","kind":"exercise","planned":true,"acquired":false,"shares":16830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vested on February 1, 2023, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 2, 2023."}],"balance_after":32827,"derivative":{"exercise_price":14.1,"exercise_date":"2023-02-01","expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":16830},"source":{"system":"sec-edgar","filing":"0000950170-24-075071","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024075071/ownership.xml","form_type":"4"}},{"id":1474664,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-06-18T21:58:48.000Z","date":"2024-06-18","kind":"sale","planned":true,"acquired":false,"shares":7179,"price":42.237,"value":303219.423,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.75 to $43.69 per share, inclusive. The reporting person undertakes to provide to Corbus Pharmaceuticals Holdings, Inc., any security holder of Corbus Pharmaceuticals Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes 73,947 restricted stock units (\"RSUs\"), which vest 25% on each of the first, second, third and fourth anniversary beginning on February 12, 2025."}],"balance_after":77221,"source":{"system":"sec-edgar","filing":"0000950170-24-075071","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024075071/ownership.xml","form_type":"4"}},{"id":1474663,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-06-18T21:58:48.000Z","date":"2024-06-18","kind":"sale","planned":true,"acquired":false,"shares":2322,"price":42.237,"value":98074.314,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.75 to $43.69 per share, inclusive. The reporting person undertakes to provide to Corbus Pharmaceuticals Holdings, Inc., any security holder of Corbus Pharmaceuticals Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes 73,947 restricted stock units (\"RSUs\"), which vest 25% on each of the first, second, third and fourth anniversary beginning on February 12, 2025."}],"balance_after":84400,"source":{"system":"sec-edgar","filing":"0000950170-24-075071","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024075071/ownership.xml","form_type":"4"}},{"id":1474662,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-06-18T21:58:48.000Z","date":"2024-06-18","kind":"exercise","planned":true,"acquired":true,"shares":2322,"price":4.26,"value":9891.72,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes 73,947 restricted stock units (\"RSUs\"), which vest 25% on each of the first, second, third and fourth anniversary beginning on February 12, 2025."}],"balance_after":86722,"source":{"system":"sec-edgar","filing":"0000950170-24-075071","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024075071/ownership.xml","form_type":"4"}},{"id":1474661,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-06-18T21:58:48.000Z","date":"2024-06-18","kind":"sale","planned":true,"acquired":false,"shares":1770,"price":42.237,"value":74759.49,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.75 to $43.69 per share, inclusive. The reporting person undertakes to provide to Corbus Pharmaceuticals Holdings, Inc., any security holder of Corbus Pharmaceuticals Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes 73,947 restricted stock units (\"RSUs\"), which vest 25% on each of the first, second, third and fourth anniversary beginning on February 12, 2025."}],"balance_after":84400,"source":{"system":"sec-edgar","filing":"0000950170-24-075071","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024075071/ownership.xml","form_type":"4"}},{"id":1474660,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-06-18T21:58:48.000Z","date":"2024-06-18","kind":"exercise","planned":true,"acquired":true,"shares":1770,"price":14.1,"value":24957.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes 73,947 restricted stock units (\"RSUs\"), which vest 25% on each of the first, second, third and fourth anniversary beginning on February 12, 2025."}],"balance_after":86170,"source":{"system":"sec-edgar","filing":"0000950170-24-075071","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024075071/ownership.xml","form_type":"4"}},{"id":1474659,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-06-18T21:58:48.000Z","date":"2024-06-18","kind":"sale","planned":true,"acquired":false,"shares":11667,"price":42.237,"value":492779.079,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.75 to $43.69 per share, inclusive. The reporting person undertakes to provide to Corbus Pharmaceuticals Holdings, Inc., any security holder of Corbus Pharmaceuticals Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes 73,947 restricted stock units (\"RSUs\"), which vest 25% on each of the first, second, third and fourth anniversary beginning on February 12, 2025."}],"balance_after":84400,"source":{"system":"sec-edgar","filing":"0000950170-24-075071","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024075071/ownership.xml","form_type":"4"}},{"id":1474658,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-06-18T21:58:48.000Z","date":"2024-06-18","kind":"exercise","planned":true,"acquired":true,"shares":11667,"price":30,"value":350010.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes 73,947 restricted stock units (\"RSUs\"), which vest 25% on each of the first, second, third and fourth anniversary beginning on February 12, 2025."}],"balance_after":96067,"source":{"system":"sec-edgar","filing":"0000950170-24-075071","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024075071/ownership.xml","form_type":"4"}},{"id":1474657,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-06-18T21:58:48.000Z","date":"2024-06-17","kind":"sale","planned":true,"acquired":false,"shares":1770,"price":46.0203,"value":81455.931,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.0 to $49.38 per share, inclusive. The reporting person undertakes to provide to Corbus Pharmaceuticals Holdings, Inc., any security holder of Corbus Pharmaceuticals Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes 73,947 restricted stock units (\"RSUs\"), which vest 25% on each of the first, second, third and fourth anniversary beginning on February 12, 2025."}],"balance_after":84400,"source":{"system":"sec-edgar","filing":"0000950170-24-075071","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024075071/ownership.xml","form_type":"4"}},{"id":1474656,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-06-18T21:58:48.000Z","date":"2024-06-17","kind":"exercise","planned":true,"acquired":true,"shares":1770,"price":4.26,"value":7540.2,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes 73,947 restricted stock units (\"RSUs\"), which vest 25% on each of the first, second, third and fourth anniversary beginning on February 12, 2025."}],"balance_after":86170,"source":{"system":"sec-edgar","filing":"0000950170-24-075071","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024075071/ownership.xml","form_type":"4"}},{"id":1474655,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-06-18T21:58:48.000Z","date":"2024-06-17","kind":"sale","planned":true,"acquired":false,"shares":9333,"price":46.0203,"value":429507.4599,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.0 to $49.38 per share, inclusive. The reporting person undertakes to provide to Corbus Pharmaceuticals Holdings, Inc., any security holder of Corbus Pharmaceuticals Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes 73,947 restricted stock units (\"RSUs\"), which vest 25% on each of the first, second, third and fourth anniversary beginning on February 12, 2025."}],"balance_after":84400,"source":{"system":"sec-edgar","filing":"0000950170-24-075071","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024075071/ownership.xml","form_type":"4"}},{"id":1474654,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-06-18T21:58:48.000Z","date":"2024-06-17","kind":"exercise","planned":true,"acquired":true,"shares":9333,"price":30,"value":279990.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes 73,947 restricted stock units (\"RSUs\"), which vest 25% on each of the first, second, third and fourth anniversary beginning on February 12, 2025."}],"balance_after":93733,"source":{"system":"sec-edgar","filing":"0000950170-24-075071","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024075071/ownership.xml","form_type":"4"}},{"id":1474653,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-06-18T21:58:48.000Z","date":"2024-06-14","kind":"sale","planned":true,"acquired":false,"shares":12487,"price":50.1662,"value":626425.3394,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.27 to $52.23 per share, inclusive. The reporting person undertakes to provide to Corbus Pharmaceuticals Holdings, Inc., any security holder of Corbus Pharmaceuticals Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes 73,947 restricted stock units (\"RSUs\"), which vest 25% on each of the first, second, third and fourth anniversary beginning on February 12, 2025."}],"balance_after":84400,"source":{"system":"sec-edgar","filing":"0000950170-24-075071","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024075071/ownership.xml","form_type":"4"}},{"id":1474652,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-06-18T21:58:48.000Z","date":"2024-06-14","kind":"exercise","planned":true,"acquired":true,"shares":12487,"price":4.26,"value":53194.62,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes 73,947 restricted stock units (\"RSUs\"), which vest 25% on each of the first, second, third and fourth anniversary beginning on February 12, 2025."}],"balance_after":96887,"source":{"system":"sec-edgar","filing":"0000950170-24-075071","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024075071/ownership.xml","form_type":"4"}},{"id":1474651,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-06-18T21:58:48.000Z","date":"2024-06-14","kind":"sale","planned":true,"acquired":false,"shares":16830,"price":50.1662,"value":844297.146,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.27 to $52.23 per share, inclusive. The reporting person undertakes to provide to Corbus Pharmaceuticals Holdings, Inc., any security holder of Corbus Pharmaceuticals Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes 73,947 restricted stock units (\"RSUs\"), which vest 25% on each of the first, second, third and fourth anniversary beginning on February 12, 2025."}],"balance_after":84400,"source":{"system":"sec-edgar","filing":"0000950170-24-075071","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024075071/ownership.xml","form_type":"4"}},{"id":1474650,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-06-18T21:58:48.000Z","date":"2024-06-14","kind":"exercise","planned":true,"acquired":true,"shares":16830,"price":14.1,"value":237303.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amount includes 73,947 restricted stock units (\"RSUs\"), which vest 25% on each of the first, second, third and fourth anniversary beginning on February 12, 2025."}],"balance_after":101230,"source":{"system":"sec-edgar","filing":"0000950170-24-075071","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000095017024075071/ownership.xml","form_type":"4"}},{"id":1642627,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-02-14T20:19:43.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":73947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on February 12, 2025, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 12, 2025."}],"balance_after":73947,"derivative":{"exercise_price":23,"expiration_date":"2034-02-12","underlying":"Common Stock","underlying_shares":73947},"source":{"system":"sec-edgar","filing":"0001209191-24-003336","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919124003336/doc4.xml","form_type":"4"}},{"id":1642626,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-02-14T20:19:43.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":73947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 12, 2024, the Reporting Person was granted 73,947 restricted stock units (\"RSUs\"), which will be settled in shares of common stock, par value $0.0001.25% of the RSUs shall vest on each of the first, second, third and fourth anniversary beginning on February 12, 2025. Notwithstanding the foregoing, upon termination of the Reporting Person's Service by the Company without cause, provided that such termination occurs after the first Vesting Date, then a pro rata portion of the RSUs shall accelerate in an amount equal to the product of (x) the number of RSUs scheduled to vest on the next Vesting Date and (y) a fraction, the numerator of which is the number of completed months of service the Awardee worked since the most recent Vesting Date through the date of Awardees termination of Service and the denominator of which is 12. The RSUs, to the extent not accelerated in accordance with this paragraph shall be forfeited upon such Reporting Person's termination of service."}],"balance_after":84400,"source":{"system":"sec-edgar","filing":"0001209191-24-003336","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919124003336/doc4.xml","form_type":"4"}},{"id":1666270,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Options to purchase common stock","published_at":"2024-01-30T21:56:07.000Z","date":"2024-01-26","kind":"exercise","planned":false,"acquired":false,"shares":7179,"price":4.97,"value":35679.63,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":4.97,"exercise_date":"2014-02-28","expiration_date":"2014-01-29","underlying":"Common stock","underlying_shares":7179},"source":{"system":"sec-edgar","filing":"0001209191-24-002419","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919124002419/doc4.xml","form_type":"4"}},{"id":1666269,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-01-30T21:56:07.000Z","date":"2024-01-26","kind":"exercise","planned":false,"acquired":true,"shares":7179,"price":4.97,"value":35679.63,"ownership":{"direct":true},"balance_after":7179,"source":{"system":"sec-edgar","filing":"0001209191-24-002419","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919124002419/doc4.xml","form_type":"4"}},{"id":2013187,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-15T17:44:21.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":1989546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on February 13 2024, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 13, 2024."}],"balance_after":1949546,"derivative":{"exercise_price":0.142,"expiration_date":"2033-02-13","underlying":"Common Stock","underlying_shares":1989546},"source":{"system":"sec-edgar","filing":"0001209191-23-009631","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919123009631/doc4.xml","form_type":"4"}},{"id":2187793,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-08-11T13:55:47.000Z","date":"2022-08-10","kind":"purchase","acquired":true,"shares":3800,"price":0.264,"value":1003.2,"ownership":{"direct":true},"balance_after":98230,"source":{"system":"sec-edgar","filing":"0001209191-22-045358","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919122045358/doc4.xml","form_type":"4"}},{"id":2269792,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-05-16T14:41:01.000Z","date":"2022-05-16","kind":"purchase","acquired":true,"shares":10500,"price":0.25,"value":2625.0,"ownership":{"direct":true},"balance_after":94430,"source":{"system":"sec-edgar","filing":"0001209191-22-029030","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919122029030/doc4.xml","form_type":"4"}},{"id":2341102,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-03-09T15:37:52.000Z","date":"2022-03-09","kind":"purchase","acquired":true,"shares":8600,"price":0.37,"value":3182.0,"ownership":{"direct":true},"balance_after":83930,"source":{"system":"sec-edgar","filing":"0001209191-22-017449","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919122017449/doc4.xml","form_type":"4"}},{"id":2415829,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-02T22:51:58.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":1489700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on February 1, 2023, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 2, 2023."}],"balance_after":1489700,"derivative":{"exercise_price":0.47,"expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":1489700},"source":{"system":"sec-edgar","filing":"0001209191-22-006515","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919122006515/doc4.xml","form_type":"4"}},{"id":2878731,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-04T21:35:22.000Z","date":"2021-02-02","kind":"grant","acquired":true,"shares":956500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents a special retention award comprised of options to purchase common stock. 25% of the option vests on February 2, 2022, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 2, 2022"}],"balance_after":956500,"derivative":{"exercise_price":2.58,"expiration_date":"2031-02-02","underlying":"Common Stock","underlying_shares":956500},"source":{"system":"sec-edgar","filing":"0001209191-21-007741","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919121007741/doc4.xml","form_type":"4"}},{"id":2878730,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-04T21:35:22.000Z","date":"2021-02-02","kind":"grant","acquired":true,"shares":956500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on February 2, 2022, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 2, 2022."}],"balance_after":956500,"derivative":{"exercise_price":2.58,"expiration_date":"2031-02-02","underlying":"Common Stock","underlying_shares":956500},"source":{"system":"sec-edgar","filing":"0001209191-21-007741","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919121007741/doc4.xml","form_type":"4"}},{"id":2982652,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-11-12T15:28:44.000Z","date":"2020-11-11","kind":"purchase","acquired":true,"shares":4240,"price":1.209,"value":5126.16,"ownership":{"direct":true},"balance_after":75330,"source":{"system":"sec-edgar","filing":"0001209191-20-057851","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919120057851/doc4.xml","form_type":"4"}},{"id":3204167,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-03-17T17:14:48.000Z","date":"2020-03-17","kind":"purchase","acquired":true,"shares":4300,"price":3.49,"value":15007.0,"ownership":{"direct":true},"balance_after":71090,"source":{"system":"sec-edgar","filing":"0001209191-20-019502","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919120019502/doc4.xml","form_type":"4"}},{"id":3219829,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option(right to buy)","published_at":"2020-03-09T21:31:59.000Z","date":"2020-03-06","kind":"grant","acquired":true,"shares":639000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on March 6, 2021, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on April 6, 2021."}],"balance_after":639000,"derivative":{"exercise_price":4.53,"expiration_date":"2030-03-06","underlying":"Common Stock","underlying_shares":639000},"source":{"system":"sec-edgar","filing":"0001209191-20-017413","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919120017413/doc4.xml","form_type":"4"}},{"id":3374023,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-11-12T18:02:00.000Z","date":"2019-11-12","kind":"purchase","acquired":true,"shares":1430,"price":4.26,"value":6091.8,"ownership":{"direct":true},"balance_after":66790,"source":{"system":"sec-edgar","filing":"0001209191-19-055941","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919119055941/doc4.xml","form_type":"4"}},{"id":3440764,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-08-12T14:37:58.000Z","date":"2019-08-12","kind":"purchase","acquired":true,"shares":1175,"price":6.056,"value":7115.8,"ownership":{"direct":true},"balance_after":65360,"source":{"system":"sec-edgar","filing":"0001209191-19-045444","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919119045444/doc4.xml","form_type":"4"}},{"id":3527249,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-05-14T13:47:06.000Z","date":"2019-05-13","kind":"purchase","acquired":true,"shares":995,"price":6.9898,"value":6954.851,"ownership":{"direct":true},"balance_after":64185,"source":{"system":"sec-edgar","filing":"0001209191-19-029514","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919119029514/doc4.xml","form_type":"4"}},{"id":3594773,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-03-14T15:25:56.000Z","date":"2019-03-14","kind":"purchase","acquired":true,"shares":1530,"price":6.49,"value":9929.7,"ownership":{"direct":true},"balance_after":63190,"source":{"system":"sec-edgar","filing":"0001209191-19-019345","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919119019345/doc4.xml","form_type":"4"}},{"id":3691571,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option(right to buy)","published_at":"2019-01-18T21:59:54.000Z","date":"2019-01-18","kind":"grant","acquired":true,"shares":565000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on January 18, 2020, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on February 18, 2020."}],"balance_after":565000,"derivative":{"exercise_price":7.53,"expiration_date":"2029-01-18","underlying":"Common Stock","underlying_shares":565000},"source":{"system":"sec-edgar","filing":"0001209191-19-004579","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919119004579/doc4.xml","form_type":"4"}},{"id":3930229,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-05-16T12:46:56.000Z","date":"2018-05-15","kind":"purchase","acquired":true,"shares":1725,"price":5.85,"value":10091.25,"ownership":{"direct":true},"balance_after":61660,"source":{"system":"sec-edgar","filing":"0001209191-18-030366","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919118030366/doc4.xml","form_type":"4"}},{"id":3994127,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-03-15T13:48:57.000Z","date":"2018-03-14","kind":"purchase","acquired":true,"shares":1160,"price":6.885,"value":7986.6,"ownership":{"direct":true},"balance_after":59935,"source":{"system":"sec-edgar","filing":"0001209191-18-019757","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919118019757/doc4.xml","form_type":"4"}},{"id":4105005,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option(right to buy)","published_at":"2018-01-05T22:27:26.000Z","date":"2018-01-04","kind":"grant","acquired":true,"shares":437500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on January 4, 2019, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on February 4, 2019."}],"balance_after":437500,"derivative":{"exercise_price":8.35,"expiration_date":"2028-01-04","underlying":"Common Stock","underlying_shares":437500},"source":{"system":"sec-edgar","filing":"0001209191-18-002512","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919118002512/doc4.xml","form_type":"4"}},{"id":4164930,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-11-13T13:59:57.000Z","date":"2017-11-10","kind":"purchase","acquired":true,"shares":1000,"price":7.1685,"value":7168.5,"ownership":{"direct":true},"balance_after":58775,"source":{"system":"sec-edgar","filing":"0001209191-17-060145","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919117060145/doc4.xml","form_type":"4"}},{"id":4236241,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-08-11T17:17:39.000Z","date":"2017-08-11","kind":"purchase","acquired":true,"shares":1695,"price":6,"value":10170.0,"ownership":{"direct":true},"balance_after":57775,"source":{"system":"sec-edgar","filing":"0001209191-17-048535","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919117048535/doc4.xml","form_type":"4"}},{"id":4322245,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-05-12T13:03:02.000Z","date":"2017-05-11","kind":"purchase","acquired":true,"shares":3250,"price":6.012,"value":19539.0,"ownership":{"direct":true},"balance_after":56080,"source":{"system":"sec-edgar","filing":"0001209191-17-031700","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919117031700/doc4.xml","form_type":"4"}},{"id":4379112,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Options to purchase common stock","published_at":"2017-03-17T11:58:12.000Z","date":"2017-03-16","kind":"exercise","acquired":false,"shares":20000,"price":1,"value":20000.0,"ownership":{"direct":true},"balance_after":272728,"derivative":{"exercise_price":1,"exercise_date":"2015-04-11","expiration_date":"2024-04-11","underlying":"Common stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-17-021246","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919117021246/doc4.xml","form_type":"4"}},{"id":4379111,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-03-17T11:58:12.000Z","date":"2017-03-16","kind":"exercise","acquired":true,"shares":20000,"price":1,"value":20000.0,"ownership":{"direct":true},"balance_after":52830,"source":{"system":"sec-edgar","filing":"0001209191-17-021246","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919117021246/doc4.xml","form_type":"4"}},{"id":4402406,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option(right to buy)","published_at":"2017-03-03T21:17:55.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":377500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on March 1, 2018, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on April 1, 2018."}],"balance_after":377500,"derivative":{"exercise_price":9.05,"expiration_date":"2027-03-01","underlying":"Common Stock","underlying_shares":377500},"source":{"system":"sec-edgar","filing":"0001209191-17-017470","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919117017470/doc4.xml","form_type":"4"}},{"id":4484974,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-01-20T22:28:37.000Z","date":"2016-11-22","kind":"purchase","acquired":true,"shares":1340,"price":7.64,"value":10237.6,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This amendment is being filed solely for the purpose of correcting the number of securities reported in Box 5 to Table 1 to indicate the number of securities beneficially owned following the transaction."}],"balance_after":32830,"source":{"system":"sec-edgar","filing":"0001209191-17-004954","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919117004954/doc4a.xml","form_type":"4/A","original_submission_date":"2016-11-23"}},{"id":4542578,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2016-11-23T16:44:51.000Z","date":"2016-11-22","kind":"purchase","acquired":true,"shares":1340,"price":7.64,"value":10237.6,"ownership":{"direct":true},"balance_after":12830,"source":{"system":"sec-edgar","filing":"0001209191-16-151867","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919116151867/doc4.xml","form_type":"4"}},{"id":4582412,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":24936,"kind":"person","name":"Cohen Yuval","position":1,"cik":"0001626003","reported_name":"Cohen Yuval","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option(right to buy)","published_at":"2016-10-07T20:50:37.000Z","date":"2016-10-06","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on October 6, 2017, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on November 6, 2017."}],"balance_after":150000,"derivative":{"exercise_price":8.71,"expiration_date":"2026-10-06","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-16-145413","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1595097/000120919116145413/doc4.xml","form_type":"4"}}]}